Document is current

Article History

Received: 31 July 2024

Accepted: 6 October 2025

First Online: 10 November 2025

Declarations

:

: Ethical approval for this study was obtained from the Ethics Committee of Shiraz University of Medical Sciences (approval date: 04/12/2023; reference: IR.SUMS.SCHEANUT.REC.1401.141). The trial was registered in the Iranian Registry of Clinical Trials (IRCT) under the code IRCT20211222053487N1 (registration date: 2023-09-26). The study was conducted in full accordance with the principles of the Declaration of Helsinki and the guidelines of Good Clinical Practice.All participants were informed about the objectives, procedures, potential risks, benefits, confidentiality measures, and the voluntary nature of the study. Written informed consent was obtained prior to enrollment. As the intervention was delivered online, the consent form was placed at the beginning of the main study questions, and participants indicated consent by clicking the word “Start.” Contact information for the instructor and main presenter was provided on the first page of the pre-exam to address any questions or concerns. Participants were assured of their right to withdraw from the study at any time without negative consequences.

: Not applicable.

: The authors declare no competing interests.